Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Luis Miguel Juárez Salcedo"'
Publikováno v:
Drugs in Context, Vol 9, Pp 1-15 (2020)
Therapeutic options for relapsed/refractory B-cell acute lymphoblastic leukemia have evolved in the past few years. The FDA has approved three novel therapies for this disease: inotuzumab ozogamicin (an anti-CD22 antibody–drug conjugate), blinatumo
Externí odkaz:
https://doaj.org/article/2bcd1842e3de4944a966849e55ed66c2
Publikováno v:
Drugs in Context, Vol 9, Pp 1-12 (2020)
The identification of the CD20 antigen in 1979 was the first step in what would become a therapeutic milestone opening the use of immunotherapy in hematological diseases. This protein is expressed on the surface of developing B cells, but not the ear
Externí odkaz:
https://doaj.org/article/2cbfc9397c794be4951defc1684b1475
Publikováno v:
Drugs in Context, Vol 8, Pp 1-13 (2019)
The emergence of targeted therapy for patients with hematological diseases has permanently altered the therapeutic landscape. Immunochemotherapy regimes are now more and more being replaced by targeted therapies due to superior efficacy and better sa
Externí odkaz:
https://doaj.org/article/3ef28902caec4049ad321e9731eb41eb
Publikováno v:
Drugs in Context, Vol 9, Pp 1-12 (2020)
Drugs in Context
Drugs in Context
The identification of the CD20 antigen in 1979 was the first step in what would become a therapeutic milestone opening the use of immunotherapy in hematological diseases. This protein is expressed on the surface of developing B cells, but not the ear
Publikováno v:
Drugs in Context, Vol 8, Pp 1-13 (2019)
Drugs in Context
Drugs in Context
The emergence of targeted therapy for patients with hematological diseases has permanently altered the therapeutic landscape. Immunochemotherapy regimes are now more and more being replaced by targeted therapies due to superior efficacy and better sa
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Publikováno v:
Annals of translational medicine. 7(Suppl 8)
Progressive multifocal leukoencephalopathy (PML) is an opportunist viral infection predominantly seen in immunosuppressed patients (most commonly in HIV cases, lymphoproliferative disorders and primary immunodeficiency) (1,2). This aggressive brain i
Publikováno v:
Case Reports in Hematology. 4/2/2017, p1-4. 4p.
Adverse events of radioimmunotherapy for non-Hodgkin lymphoma: A systematic review and meta-analysis
Autor:
Luis Miguel Juárez-Salcedo, Samir Dalia, Hanan Gruhonjic, Bharat S. Ponnaganti, Catherine H. Hanna, Rahul Mhaskar, Esha Sharda, Raahil S. Patel
Publikováno v:
Leukemia Research. 108:106615
Non-Hodgkin's lymphoma continues to be a highly prevalent entity in the general population. Currently, there are multiple treatment schemes based on chemotherapeutic agents with a great success rate. However, there is a non-negligible percentage of p
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.